Edesa Biotech, Inc. (EDSA) Form 8-K — Oct 23, 2026
Edesa Biotech's board approved significant base salary increases for its three senior executives, retroactive to July 1, 2026. CEO Dr. Pardeep Nijhawan's salary rises from $357,696 to $657,423, President Dr. Michael Brooks's from $335,340 to $591,681, and CFO Peter Weiler's from $300,000 to $525,938.
Key figures
- Ceo salary new
- 657423
- Cfo salary new
- 525938
- Ceo salary prior
- 357696
- Cfo salary prior
- 300000
- President salary new
- 591681
- President salary prior
- 335340
- Salary increase effective
- retroactive to July 1, 2026
- Last prior salary adjustment
- 2023
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.